[PDF][PDF] Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma

…, DT Maglinte, HS Mahadeshwar, MA Marra, M McGraw… - Cell, 2016 - cell.com
Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic
glioma driving alterations and suboptimal disease classification. We defined the complete …

Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma

…, M Clampitt, C Brewer, J Jochum, MV McGraw… - Journal of …, 2013 - thejns.org
Object Laser interstitial thermal therapy has been used as an ablative treatment for glioma;
however, its development was limited due to technical issues. The NeuroBlate System …

Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation

…, B Klare, G Zacchello, I Bjorn Brekke, M McGraw… - Pediatric …, 2002 - Springer
This study was undertaken to compare the efficacy and safety of tacrolimus (Tac) with the
microemulsion formulation of cyclosporin (CyA) in children undergoing renal transplantation. A …

Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

…, G Roversi, DC Watson, A Lo, TJ Alban, M McGraw… - Cancer discovery, 2020 - AACR
Sexual dimorphism at the level of MDSC subset prevalence, localization, and gene-expression
profile constitutes a therapeutic opportunity. Our results indicate that chemotherapy can …

[HTML][HTML] Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis

…, M Sinyuk, JS Hale, GR Onzi, M McGraw… - JCI insight, 2018 - ncbi.nlm.nih.gov
Glioblastoma (GBM) remains uniformly lethal, and despite a large accumulation of immune
cells in the microenvironment, there is limited antitumor immune response. To overcome …

[HTML][HTML] Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

…, AG Alvarado, B Otvos, D Bayik, G Roversi, M McGraw… - JCI insight, 2019 - ncbi.nlm.nih.gov
BACKGROUND Myeloid-derived suppressor cells (MDSCs) are elevated in the circulation
of patients with glioblastoma (GBM), present in tumor tissue, and associated with poor …

Sex-biased T-cell exhaustion drives differential immune responses in glioblastoma

…, A Lauko, KE Kay, SZ Wang, S Johnson, M McGraw… - Cancer discovery, 2023 - AACR
Immunotherapies in patients with GBM have been unsuccessful due to a variety of factors,
including the highly immunosuppressive tumor microenvironment in GBM. This study …

Four‐year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion

…, M Griebel, IB Brekke, M McGraw… - Pediatric …, 2005 - Wiley Online Library
This study was undertaken to compare the efficacy and safety of tacrolimus (Tac) with cyclosporin
microemulsion (CyA) in pediatric renal recipients. A 6‐month, randomized, prospective…

Republished paper: Assuring validity of multisource feedback in a national programme

J Archer, M McGraw, H Davies - Postgraduate medical journal, 2010 - academic.oup.com
Objective To report the evidence for and challenges to the validity of Sheffield Peer Review
Assessment Tool (SPRAT) with paediatric Specialist Registrars (SpRs) across the UK as part …

Neurologic-developmental sequelae of chronic renal failure in infancy

ME McGraw, K Haka-Ikse - The Journal of pediatrics, 1985 - Elsevier
Twelve children who have had chronic renal failure since infancy and underwent early
dialysis (mean age 18 months) and early transplantation (mean age 28 months) were studied. …